BiotechTube

Lyrica (pregabalin) + Placebo

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Postherpetic Neuralgia ( PHN )

Conditions

Postherpetic Neuralgia ( PHN )

Trial Timeline

Dec 1, 2011 → Jan 1, 2014

NCT ID
NCT01455428

About Lyrica (pregabalin) + Placebo

Lyrica (pregabalin) + Placebo is a approved stage product being developed by Pfizer for Postherpetic Neuralgia ( PHN ). The current trial status is completed. This product is registered under clinical trial identifier NCT01455428. Target conditions include Postherpetic Neuralgia ( PHN ).

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT01455428ApprovedCompleted
NCT00351611ApprovedCompleted

Competing Products

20 competing products in Postherpetic Neuralgia ( PHN )

See all competitors
ProductCompanyStageHype Score
QUTENZAAstellas PharmaApproved
85
KHK6188 + PlaceboKyowa KirinPhase 2
52
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Placebo + Pregabalin SR tablet 165mg/day + Pregabalin SR tablet 330mg/day + Pregabalin SR tablet 660mg/dayJiangsu Hengrui MedicinePhase 3
77
MK-8291 + PlaceboMerckPhase 1
33
Etoricoxib + PlaceboMerckApproved
85
ADL5747 + Placebo + PregabalinMerckPhase 2
52
MK0759MerckPhase 2
52
MK0686MerckPhase 2
52
Comparator: pregabalin + Comparator: Placebo (unspecified)MerckPhase 1
33
RN624 + RN624 + PlaceboPfizerPhase 2
51
T-62PfizerPhase 2
51
pregabalin + pregabalin/PF-00489791 + PlaceboPfizerPhase 2
51
PH-797804 + PlaceboPfizerPhase 2
51
Placebo + Pregabalin + Pregabalin + PregabalinPfizerPhase 3
76
pregabalinPfizerPhase 3
76
pregabalinPfizerApproved
84
T-62 Dose 1 + T-62 Dose 2PfizerPhase 2
51
HSK16149 20mg BID + HSK16149 40mg BID + Placebo BIDHaisco Pharmaceutical GroupPhase 3
74
LevetiracetamUCBPhase 2
49

Other Products from Pfizer

MeropenemApproved
84
celecoxibApproved
84
13vPnCApproved
84
EtanerceptApproved
84
AtorvastatinApproved
84